Device Trial Radar · NCT07928973
Clinical Application of a Novel Corneal Biomechanical Device in Refractive Surgery
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Nov 4, 2026
Primary completion
Nov 1, 2027
Study completion Oct 31, 2028
Sponsor
- Lead sponsor
- Tianjin Eye HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 10, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to evaluate the accuracy of corneal Young's modulus measurements (E\_Steady-State) obtained using a steady-state corneal biomechanical measurement device in patients scheduled to undergo refractive surgery and to explore their potential applications in assisting refractive surgical procedures.
Conditions
- Corneal Biomechanics
- Refractive Surgery
Interventions
Corneal steady-state biomechanical measurement device, Pentacam and Corvis STDevice
Participants wear negative-pressure goggles, and a pressure test is performed to ensure an adequate seal. They then position their chin on the chinrest and fixate on a target while the operator aligns the imaging system with the cornea. The device applies controlled negative pressure and captures corneal deformation images using a Scheimpflug camera, with a coaxial imaging system assisting in alignment and monitoring eye movements. Following data acquisition, the software analyzes corneal biomechanical parameters and generates an assessment report.Perform surgery based on biomechanical parameters obtained from corneal steady-state biomechanical measurement device.
Pentacam and Corvis STDevice
Morphological and biomechanical parameters were obtained by Pentacam and Corvis ST. Perform refractive surgery based on the surgeon's experience.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Postoperative residual refractive errorTime frame: One year
- Visual acuityTime frame: One year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tianjin Eye Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.